Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 219

1.

The Effects of Air Pollution on Asthma Hospital Admissions in Adelaide, South Australia, 2003-2013: Time-Series and Case-crossover Analyses.

Chen K, Glonek G, Hansen A, Williams S, Tuke J, Salter A, Bi P.

Clin Exp Allergy. 2016 Aug 11. doi: 10.1111/cea.12795. [Epub ahead of print]

PMID:
27513706
2.

Exploring the feasibility and acceptability of sensor monitoring of gait and falls in the homes of persons with multiple sclerosis.

Newland P, Wagner JM, Salter A, Thomas FP, Skubic M, Rantz M.

Gait Posture. 2016 Jul 7;49:277-282. doi: 10.1016/j.gaitpost.2016.07.005. [Epub ahead of print]

PMID:
27474948
3.

Improving the sustainability of global meat and milk production.

Salter AM.

Proc Nutr Soc. 2016 Jul 15:1-6. [Epub ahead of print]

PMID:
27417542
4.

Anaerobic digestion of spring and winter wheat: Comparison of net energy yields.

Rincón B, Heaven S, Salter AM, Banks CJ.

J Environ Sci Health A Tox Hazard Subst Environ Eng. 2016 Oct 14;51(12):1084-9. doi: 10.1080/10934529.2016.1198634. Epub 2016 Jul 13.

PMID:
27409161
5.

Declines in the diagnosis of primary progressive MS: A critical change in phenotype or critical measurement error?

Cutter GR, Salter A, Marrie RA.

Mult Scler. 2016 Jul;22(8):983-5. doi: 10.1177/1352458516655218. No abstract available.

PMID:
27385768
6.

Health insurance affects the use of disease-modifying therapy in multiple sclerosis.

Wang G, Marrie RA, Salter AR, Fox R, Cofield SS, Tyry T, Cutter GR.

Neurology. 2016 Jul 26;87(4):365-74. doi: 10.1212/WNL.0000000000002887. Epub 2016 Jun 29.

PMID:
27358338
7.

Symptomatic Management of Multiple Sclerosis-Associated Tremor Among Participants in the NARCOMS Registry.

Meador W, Salter AR, Rinker JR 2nd.

Int J MS Care. 2016 May-Jun;18(3):147-53. doi: 10.7224/1537-2073.2015-008.

8.

Relationship between symptom change, relapse activity and disability progression in multiple sclerosis.

Liu Y, Morgan C, Hornung L, Tyry T, Salter AR, Agashivala N, Belletti DA, Kim E, Fox RJ, Cofield SS, Cutter GR.

J Neurol Sci. 2016 Mar 15;362:121-6. doi: 10.1016/j.jns.2016.01.034. Epub 2016 Jan 19.

PMID:
26944131
9.

Maternal high-fat feeding in pregnancy programs atherosclerotic lesion size in the ApoE*3 Leiden mouse.

Tarling EJ, Ryan KJ, Austin R, Kugler SJ, Salter AM, Langley-Evans SC.

J Dev Orig Health Dis. 2016 Feb 2:1-8. [Epub ahead of print]

PMID:
26829884
10.

Saturated fatty acids and coronary heart disease risk: the debate goes on.

Williams CM, Salter A.

Curr Opin Clin Nutr Metab Care. 2016 Mar;19(2):97-102. doi: 10.1097/MCO.0000000000000248.

PMID:
26727348
11.

Prevalence of multiple sclerosis symptoms across lifespan: data from the NARCOMS Registry.

Fox RJ, Bacon TE, Chamot E, Salter AR, Cutter GR, Kalina JT, Kister I.

Neurodegener Dis Manag. 2015;5(6 Suppl):3-10. doi: 10.2217/nmt.15.55.

12.

A BiTE from cancer's intracellular menu.

Salter AI, Riddell SR.

Nat Biotechnol. 2015 Oct;33(10):1040-1. doi: 10.1038/nbt.3370. No abstract available.

PMID:
26448086
13.

Two-group time-to-event continual reassessment method using likelihood estimation.

Salter A, O'Quigley J, Cutter GR, Aban IB.

Contemp Clin Trials. 2015 Nov;45(Pt B):340-5. doi: 10.1016/j.cct.2015.09.016. Epub 2015 Sep 25.

PMID:
26409251
14.

Causes of death among persons with multiple sclerosis.

Cutter GR, Zimmerman J, Salter AR, Knappertz V, Suarez G, Waterbor J, Howard VJ, Marrie RA.

Mult Scler Relat Disord. 2015 Sep;4(5):484-90. doi: 10.1016/j.msard.2015.07.008. Epub 2015 Jul 18.

PMID:
26346799
15.

Bias and Precision of the "Multiple Imputation, Then Deletion" Method for Dealing With Missing Outcome Data.

Sullivan TR, Salter AB, Ryan P, Lee KJ.

Am J Epidemiol. 2015 Sep 15;182(6):528-34. doi: 10.1093/aje/kwv100. Epub 2015 Sep 2.

PMID:
26337075
16.

Role of SHIP1 in Invariant NKT Cell Development and Functions.

Anderson CK, Salter AI, Toussaint LE, Reilly EC, Fugère C, Srivastava N, Kerr WG, Brossay L.

J Immunol. 2015 Sep 1;195(5):2149-56. doi: 10.4049/jimmunol.1500567. Epub 2015 Jul 31.

PMID:
26232432
17.

Implementation of a two-group likelihood time-to-event continual reassessment method using SAS.

Salter A, Morgan C, Aban IB.

Comput Methods Programs Biomed. 2015 Oct;121(3):189-96. doi: 10.1016/j.cmpb.2015.06.001. Epub 2015 Jun 16.

PMID:
26122068
18.

Risk tolerance to MS therapies: Survey results from the NARCOMS registry.

Fox RJ, Salter A, Alster JM, Dawson NV, Kattan MW, Miller D, Ramesh S, Tyry T, Wells BW, Cutter G.

Mult Scler Relat Disord. 2015 May;4(3):241-9. doi: 10.1016/j.msard.2015.03.003. Epub 2015 Mar 26.

PMID:
26008941
19.

Impact of multiple sclerosis relapse: The NARCOMS participant perspective.

Nickerson M, Cofield SS, Tyry T, Salter AR, Cutter GR, Marrie RA.

Mult Scler Relat Disord. 2015 May;4(3):234-40. doi: 10.1016/j.msard.2015.03.005. Epub 2015 Mar 27.

20.

Improvement of multiple sclerosis-associated tremor as a treatment effect of natalizumab.

Rinker JR 2nd, Salter AR, Cutter GR.

Mult Scler Relat Disord. 2014 Jul;3(4):505-12. doi: 10.1016/j.msard.2014.04.001. Epub 2014 Apr 8.

PMID:
25877063
Items per page

Supplemental Content

Loading ...
Write to the Help Desk